Fluticasone Propionate And Salmeterol Xinafoate



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Asthma 47.3%
Myocardial Ischaemia 6.2%
Hypertension 4.7%
Migraine 4.7%
Osteoarthritis 4.7%
Rhinitis Allergic 3.9%
Varicose Vein 3.9%
Chronic Obstructive Pulmonary Disease 3.1%
Hiv Infection 3.1%
Respiratory Tract Infection 3.1%
Bronchial Hyperreactivity 2.3%
Type 2 Diabetes Mellitus 2.3%
Blood Pressure Abnormal 1.6%
Deep Vein Thrombosis 1.6%
Epilepsy 1.6%
Hiatus Hernia 1.6%
Hypothyroidism 1.6%
Ill-defined Disorder 1.6%
Bronchitis Chronic 0.8%
Gastrooesophageal Reflux Disease 0.8%
Allergic Granulomatous Angiitis 13.5%
Intentional Overdose 8.1%
Paraesthesia 8.1%
Small For Dates Baby 8.1%
Breast Cancer 5.4%
Increased Upper Airway Secretion 5.4%
Off Label Use 5.4%
Palatal Oedema 5.4%
Syndactyly 5.4%
Thrombocytopenia 5.4%
Unresponsive To Stimuli 5.4%
Blindness Transient 2.7%
Chronic Obstructive Pulmonary Disease 2.7%
Dysaesthesia 2.7%
Feeling Abnormal 2.7%
Gait Disturbance 2.7%
Gastrointestinal Haemorrhage 2.7%
Haemangioma 2.7%
Hypoglycaemia 2.7%
Meningitis 2.7%
Concomitant
Asthma 52.0%
Hypertension 6.8%
Osteoporosis 6.3%
Chronic Obstructive Pulmonary Disease 6.1%
Pain 3.0%
Essential Hypertension 2.3%
Prophylaxis 2.3%
Hypercholesterolaemia 2.2%
Type 2 Diabetes Mellitus 2.1%
Hiv Infection 1.9%
Ill-defined Disorder 1.7%
Arthralgia 1.5%
Depression 1.5%
Diabetes Mellitus 1.5%
Food Allergy 1.5%
Osteoporosis Postmenopausal 1.5%
Back Pain 1.4%
Cerebrovascular Accident Prophylaxis 1.4%
Gastrooesophageal Reflux Disease 1.4%
Atrial Fibrillation 1.3%
Allergic Granulomatous Angiitis 24.3%
Femur Fracture 9.6%
Prescribed Overdose 8.8%
Rhabdomyolysis 6.6%
Suicide Attempt 6.6%
Overdose 3.7%
Polyneuropathy 3.7%
Red Blood Cell Sedimentation Rate Increased 3.7%
Suicidal Ideation 3.7%
Osteonecrosis 2.9%
Sensory Disturbance 2.9%
Syncope 2.9%
Talipes 2.9%
Thrombocytopenia 2.9%
Vertigo 2.9%
Vomiting 2.9%
Alopecia 2.2%
Blood Bilirubin Increased 2.2%
Chest Pain 2.2%
Drug Rash With Eosinophilia And Systemic Symptoms 2.2%